QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS5-Region Domestic Shipping
What is Telmisartan?
Telmisartan is an AT1R antagonist with unique secondary pharmacology: partial PPARγ agonism — unique among ARBs, producing metabolic benefits (insulin sensitisation, adiponectin upregulation) without full PPARγ agonist side effects. Research: RAS pharmacology, dual AT1R/PPARγ biology, metabolic-cardiovascular interaction, longevity. CAS 144701-48-4.
Research Applications
AT1R Antagonism
Angiotensin II blockade — RAS pharmacology, cardiac remodelling
PPARγ Partial Agonism
Unique among ARBs — metabolic benefits, insulin sensitisation
Metabolic-Cardiovascular
Dual RAS/PPARγ — comparative vs pure ARBs and TZDs
Longevity Research
RAS blockade extends lifespan in rodent ageing models
Renal Protection
AT1R-mediated renal fibrosis, podocyte protection, diabetic nephropathy
Quick Specs
| Form | Tablet — 40mg per tablet, 100-tablet bottle |
| CAS Number | 144701-48-4 |
| Molecular Formula | C₃₃H₃₀N₄O₂ |
| Molecular Weight | 514.6 g/mol |
| Compound Type | AT1R antagonist / PPARγ partial agonist |
| Purity | ≥99% by HPLC — every batch |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage |
| Shelf Life | 24 months unopened |

